Ray Co

Ray Co EBIT Growth

The Year-over-Year EBIT Growth of Ray Co (228670.KQ) as of Nov 18, 2026 is 79.76 %. In the previous year, Year-over-Year EBIT Growth was -2,734.77 % — a change of -102.92% (higher).

EBIT Growth

79.76 %

YoY

-102.92%

Last updated:

Year-over-Year EBIT Growth of Ray Co is 2025 79.76 % . Year-over-Year EBIT Growth of Ray Co was 2024 -2,734.77 % . It decreases by -102.92% higher compared to the previous year.

The Ray Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
210.78 KRW
Jan 1, 2019
112.66 KRW
Jan 1, 2020
-64.38 KRW
Jan 1, 2021
-76.44 KRW
Jan 1, 2022
1,401.63 KRW
Jan 1, 2023
-88.67 KRW
Jan 1, 2024
-2,734.77 KRW
Jan 1, 2025
79.76 KRW
The Ray Co EBIT Growth history
YEAREBIT GrowthYoY
79.76 %-102.92%
-2,734.77 %+2,984.05%
-88.67 %-106.33%
1,401.63 %-1,933.64%
-76.44 %+18.72%
-64.38 %-157.15%
112.66 %-46.55%
210.78 %+349.68%
46.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Year-over-Year EBIT Growth of Ray Co is 79.76 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Ray Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Ray Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Ray Co

All Key Metrics — Ray Co